hotspot -WSS

hotspot

author：knowledge 2025-09-28 15:20:54 - browse：3

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Alkermes shareholders re
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

hotspot

WSS

Why the world’s most expensive drug might be worth the price

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

AstraZeneca stays mum on Medicare drug pricing negotiations

Food as medicine: Medically tailored meals may get standardized

Readout LOUD podcast: mifepristone case, GLP

Top private equity targets in 2023: cardiology, clinical trials, lasers

leisure time

hotspot

MORE: General Motors recalls over 600K cars due to car seat safety issue

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

The Readout: Lenmeldy, GLP

State Dept. review finds Biden bears some blame for Afghanistan failures

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Heart attack and stroke risk calculators need revising

Padmanee Sharma of MD Anderson at center of lawsuit over credit

How one medical school became remarkably diverse

Texas Medical Board asked to define abortion emergency exception

23andMe had bad news about my health. I wish a person had delivered it

Abortion pill Supreme Court ruling could impact entire drug industry

explore

Abortion pill case raises question: who can sue the FDA?

Devoted Health’s losses in Medicare Advantage persist

A single Democrat is willing to weaken Medicare negotiation power

Oprah kicked off a national conversation on obesity. Let's have it

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Unique patient identifier: Experts argue the benefits, pitfalls

hotspot

leisure time

hotspot

entertainment